Global Biotechnology And Digital Automation Will Drive Future Healthcare

Published
24 Nov 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
€150.18
26.1% undervalued intrinsic discount
14 Aug
€110.95
Loading
1Y
-34.9%
7D
-0.09%

Author's Valuation

€150.2

26.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 13%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 2.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 11%

Shared on26 Mar 25
Fair value Decreased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.